title: [Clinical application of rokitamycin in pediatrics].
abstract: Rokitamycin (RKM, TMS-19-Q) was used for the treatment of infections in patients with underlying diseases. Many antibiotics are tended to be used on these patients with underlying diseases mainly for prophylactic purposes and, as a consequence, microbes resistant to antibiotics frequently become pathogens in these cases. Responses of our patients to RKM, however, were generally excellent but one who had EB virus infection.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, University of Tokyo.
authors.forename: Y
authors.initials: Y
authors.lastname: Yanagawa
authors.forename: M
authors.initials: M
authors.lastname: Fujita
authors.forename: H
authors.initials: H
authors.lastname: Hayakawa
mesh_terms: D000284:Administration, Oral; D002648:Child; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007244:Infectious Mononucleosis / Q000188:drug therapy; D007827:Laryngitis / Q000188:drug therapy; D007933:Leucomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D015644:Miocamycin / Q000031:analogs & derivatives*; D013290:Streptococcal Infections / Q000188:drug therapy*
chemical_list: D007933:Leucomycins; D015644:Miocamycin; C033383:rokitamycin